Does the UMOD rs12917707 GG genotype increase CKD risk and lower eGFR?

The UMOD rs12917707 polymorphism is one of the most consistently identified genetic factors influencing long-term kidney health. Research across multiple large-scale genome-wide association studies (GWAS) confirms that the G allele at this locus is a significant risk factor for renal decline.

Clinical evidence

• eGFR and CKD risk: Carrying the G allele is robustly associated with a lower estimated glomerular filtration rate (eGFR) and an increased risk of developing chronic kidney disease (CKD). While many studies report "per-allele" risk, the association follows an additive model, meaning individuals with the GG genotype carry the highest genetic risk compared to GT or TT carriers.
• Population data: Meta-analyses of European and multi-ethnic populations frequently identify rs12917707 as a top-tier locus for kidney function parameters. For a 58-year-old female, this genetic predisposition may compound with age-related declines in nephron mass, though the variant itself remains an independent risk factor across adult populations.

Mechanistic explanations

• Protein expression: The rs12917707 variant is located in a regulatory region that controls the transcription of the UMOD gene. The G risk allele significantly increases the production and urinary secretion of uromodulin (Tamm-Horsfall protein) in the thick ascending limb (TAL) of the loop of Henle.
• Sodium handling: Elevated uromodulin levels stabilize the Na-K-2Cl cotransporter (NKCC2) on the cell membrane. This stabilization enhances sodium reabsorption, which can lead to salt-sensitive hypertension and increased hydrostatic pressure within the nephron.
• Tubulointerstitial injury: Excessive uromodulin production can lead to protein aggregation and endoplasmic reticulum stress within TAL cells. Over decades, this promotes chronic tubulointerstitial inflammation and fibrosis, the primary pathological drivers of CKD and reduced eGFR.

Bottom line

The UMOD rs12917707 GG genotype is strongly associated with lower eGFR and increased CKD risk. This risk is driven by the overproduction of uromodulin, which alters renal salt handling and promotes progressive tissue scarring.